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Abstract (300 words max) 
Background 
To provide a validation dataset for aerosol deposition modelling, a clinical trial was 
performed in which the inhalation parameters and the inhaled aerosol were controlled or 
characterized. 
Methods 
Eleven, healthy, never-smoked, male participants completed the study. Each participant 
performed two inhalations of Tc-99m labelled aerosol from a vibrating mesh nebulizer, 
which differed by a single controlled parameter (Aerosol particle size: ‘small’ or ‘large’. 
Inhalation: ‘deep’ or ‘shallow’. Carrier gas: air or a helium/oxygen mix). The deposition 
measurements were made by planar imaging, and Single Photon Emission Computed 
Tomography – Computed Tomography (SPECT-CT). 
Results  
The difference between the mean activity measured by imaging and that delivered from 
the nebulizer was 2.7%, which was not statistically significant. 
The total activity deposited was significantly lower in the left lung than in right lung 
(p<0.0001) with a mean ratio (Left/Right) of 0.87±0.1SD. However, when normalized to 
lung air volume the left lung deposition was significantly higher (p=0.0085) with a mean 
ratio of 1.08±0.12SD. A comparison of the 3D Central-to-Peripheral (nC/P3D) ratio 
showed that it was significantly higher for left lung (p<0.0001) with a mean ratio 
(Left/Right) of 1.36±0.20SD.   
The effect of particle size was statistically significant on nC/P3D ratio (p=0.0014), ET 
deposition (p=0.0037), and 24h clearance (p<0.0001), contrary to the inhalation 
parameters which showed no effect.  
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Two participants inhaled both air and helium-oxygen. The nC/P3Dratios were lower for 
the experiments with helium-oxygen than air, suggesting that deposition was more 
peripheral when breathing helium-oxygen. 
Conclusions 
This paper presents the results of an analysis of the in vivo deposition data, obtained in 
a clinical study designed to provide data for model validation. This study has 
demonstrated the value of SPECT imaging over planar; the influence of particle size on 
regional distribution within the lung; and differences in deposition between left and right 
lungs. 
Keywords: aerosol deposition distribution, helium, SPECT, gamma imaging 
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Introduction 
To provide a validation dataset for aerosol deposition modeling a clinical study was 
designed and performed wherein as much as possible the inhalation parameters and the 
inhaled aerosol were controlled or characterized. A high resolution computed 
tomography (HRCT) x-ray scan of the respiratory tract allowed individual morphometric 
models to be created.  Parametric sets of experiments were performed where a single 
variable was changed, the goal being to isolate model limitations and to guide future 
developments. The deposition measurements themselves were made by 3-D single 
photon emission computed tomography (SPECT) imaging in combination) with low 
resolution (LR) CT that provided anatomical information for attenuation correction. The 
two LRCT images allowed for co-registration of the SPECT-CT and HRCT images.  The 
spatial deposition data was converted into generational data using the methodology 
developed by Fleming and his colleagues1.  Details of the methodology and experimental 
results are provided in two recent articles2,3. 
 
Recently we have published preliminary comparisons of the data with existing models4. 
Other papers analyzing the CT scans have appeared considering morphological 
characteristics and volume measurements5,6. Presented herein are the analyses of the 
two inhalation experiments for each of the 11 healthy, male volunteers in terms of 
imaging techniques, dose accountability, 24 hours clearance, comparison of right vs. left 
lung deposition, and influence of the controlled parameters (particle size, depth of 
breathing, carrier gas) on aerosol deposition. It is considered that these well controlled 
and characterized experiments could provide useful information in and of themselves 
without respect to modeling.   
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Materials and Methods 
A brief description of the clinical study and analysis methods appear in this section. 
 
Clinical Study 
The clinical study was performed at the Departments of Nuclear Medicine and Radiology 
of University Hospital Southampton NHS Foundation Trust Southampton, UK. Approval 
for the clinical study was obtained from the local research ethics committee and the UK 
Administration of Radioactive Substances Advisory Committee (ARSAC).  Eleven healthy, 
male participants completed the study, the first five making up a ‘pilot’ study and the 
remaining six, the ‘main’ study. The inclusion criteria were: male volunteers, aged 
between 18 and 65 years, never-smokers, and lung function tests within the normal 
range (FEV1, FVC, flow volume curves, salbutamol reversibility, TLCO and measurement 
of lung volumes).  
 
Participants inhaled isotonic saline aerosols seeded with a suspension of Tc-99m labelled 
particles of human serum albumin (Nanocoll®, GE Healthcare, UK), administered by an 
AKITA²® device (Activaero GmbH, Germany) connected to a vibrating mesh aerosol 
generator that uses TouchSpray® Technology (Pari Pharma, Germany). The AKITA²® 
device allows to control the ventilatory regime and aerosol characteristics. Two distinct 
but similar devices have been used; one for air and another one for a helium-oxygen 
mixture as the carrier gas.  
After inhalation, 3D-SPECT images were acquired with LRCT scans to account for 
attenuation. The acquisition was done with a GE Infinia dual head gamma camera with 
Hawkeye 4 CT attachment (GE Medical Systems, Milwaukee, WI, USA). The initial 
deposition of aerosol was captured by a 60-sec anterior/posterior planar image of the 
oropharynx, followed by a further 60-sec anterior/posterior acquisition of the lungs and 
stomach planar image. Then, a SPECT acquisition was completed, and followed by a 
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LRCT image of the thorax at mean tidal breathing, which provided 90 slices with an 
interslice separation of 4.42mm. A second planar anterior/posterior image was then 
acquired. This enabled an estimate of the rate of lung clearance, which could be used to 
correct activities derived from the SPECT image for this factor. Planar imaging of the 
nebulizer, the exhalation filter, and the standard was also performed afterwards. The 
following day a planar anterior/posterior image of the lungs was acquired to calculate the 
24h clearance, which is a measure of deposition in the conducting airways. 
Each subject performed two inhalations at a one week interval, totalling twenty-two 3D-
SPECT/CT experiments for all participants. For every subject, the two experiments 
differed by a single controlled parameter: particle size (small or large), depth of 
breathing (deep or shallow) or carrier gas (air or helium-oxygen mixture). One exception 
was a pilot experiment with large particles, shallow breathing and air, where the two 
experiments consisted of inhalation in the erect and then in the supine position. The 
detailed description of particle size and breathing pattern is given in Table 1 and Table 2. 
Detailed descriptions of the study can be found in previous papers2,3. 
The inspiratory flow rate was controlled by the AKITA® device and set constant to 
18L/min. However, the time for exhalation and breath hold were not controlled, as 
breaths were triggered by the subject; thus minute ventilation of 9 L/min is only an 
estimate. Measurements of breath hold and exhalation timing was done with an Embletta 
sleep diagnostic kit (Emblas, Denver,CO), and are included in the study database2,7.  
 
Analysis 
The distribution of activity in the different sections of the airway was determined from 
analysis of the planar images2.  Briefly, lung regions of interest (ROI) were obtained 
from the CT images and the activities in the lungs calculated from the geometric mean 
counts in the ROIs on anterior and posterior images after correction for radioactive 
decay, background, mucociliary clearance and attenuation. The activities in the 
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trachea/main bronchi, the oropharynx, the stomach, the exhalation filter and the amount 
remaining in the nebulizer after inhalation were also obtained from planar imaging. 
Activity in the stomach was added to that in the oropharynx to give an estimated of 
xtra-thoracic deposition. The amount of activity placed into the nebulizer was measured 
on an isotope calibrator. Dose accountability was performed by calculating the amount of 
activity leaving the nebulizer and comparing it to that obtained by summing the activity 
in the body and exhalation filter from the imaging measurements.   
 
The 3D spatial distribution of aerosol deposited in the airways was assessed using 
several parameters. The process began by dividing the right and left lung regions of 
interest, determined from the LRCT images, into 10 concentric shells or annuli from 
centre to periphery, using the hilum as the centre of the transform5. The hilum was 
taken as the first bifurcation of the main bronchus as suggested in the new guidelines for 
SPECT measurement of aerosol deposition8. The shell data were corrected for partial 
volume9 and the 3D Central-to-Peripheral ratio (C/P3D) was calculated by dividing the 
activity in the inner five 3D shells by that in the outer five: 
∑
∑
=
==
10
6i
i
5
1i
i
3D
S
S
C/P           (1) 
Where Si is the count in shell i on the SPECT image. 
As the C/P ratio has been shown to depend on lung shape9 the value was normalized to 
the 3D C/P ratio of an air volume image derived from the LRCT5. The 3D C/P ratio 
normalized to lung volume, nC/P3D, is defined by: 
imagevolumeair theofC/P
imageSPECTinitialtheofC/P
nC/P
3D
3D
3D =       (2) 
Other estimations of deposition in the conducting airways were made using the analysis 
of the SPECT data. Deposition by airway generation was calculated using a conceptual 
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model of the spatial arrangement of the lung airway generations within each shell to 
obtain a mapping to transform shell deposition into generational deposition1.  
Conducting airways deposition was calculated from the SPECT images in two ways: (i) 
based on the standard International Commission on Radiological Protection (ICRP) 
definition of the conducting airways represented by generations 2–15 (CADF, conducting 
airways deposition fraction) (ii) as defined by Weibel10 (wdf), who considered that a 
fraction of g nerations 16 to 19 were part of the conducting airways,  
∑
∑
=
=
+++
=
23
2j
j
16
2j
191817j
G
0.5.G0.75.G0.88.GG
wdf       (3) 
The bronchial airways deposition fraction, BADF, defined by generations 2 to 8 was also 
calculated.  
Deposition in the conducting airways was also derived from the 24 h image.  The activity 
in this image was analyzed as described above and, after all the corrections had been 
applied, the activity in the each lung was compared to that in the image obtained 
immediately after inhalation.  Clearance was calculated as the percentage loss of activity 
from the lung at 24 h relative to the amount in the original image. This is considered to 
be an estimate of the deposition in the conducting airways11. 
 
Statistical analysis 
Statistics were achieved using Excel (Microsoft, USA) and SAS v9.2 (SAS Institute Inc., 
USA). A p value inferior to 0.05 was considered as a significant difference.  Random 
variation between two variables was obtained after linear regression either as the 
standard error of the estimate or the coefficient of variation.   
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Results  
Analysis of SPECT/CT accuracy 
Comparison between 3D-SPECT and planar imaging 
The total aerosol deposition in the right and left lungs determined from planar (2D) and 
SPECT (3D) imaging for all the participants is compared in Figure 1. The planar values 
were systematically higher than the SPECT by 8.4%. . The random difference between 
these two measurements as determined by the coefficient of variation was 7.6%. These 
statistics were calculated after correction for mucociliary clearance of the radioaerosol 
from the lungs. The rate of clearance is determined from the change in count on the 
anterior images taken before and after the SPECT study, which is assumed to be linear. 
The mean reduction in counts due to clearance during the SPECT imaging was estimated 
to be 2.5% for the right lung and 3.7% for the left lung. Although small, the clearance 
should be noted because to do so will reduce differences, as the systematic difference 
was -11.9% before correction, vs. -8.4% after correction. 
 
Dose accountability for planar imaging  
Figure 2 shows the total activity leaving the nebulizer assessed from (i) the difference in 
activity put into the nebulizer and that left after inhalation and (ii) the sum of the activity 
accounted for in the body and exhalation filter as determined from planar imaging.  The 
mean total activity leaving the nebulizer was 86.5±29.3SD MBq (n=22). The second 
measurement obtained by summing the activity in the body and exhalation filter gave a 
mean value of 84.3±30.9SD MBq (n=22). Statistical analysis (Student’s t test) gave a p 
value of 0.0961, which indicates that there was no significant systematic difference 
between the two measurements. The random difference as measured by the coefficient 
of variation was 6.9%. 
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24 hours (24h) clearance  
The 24h clearance is compared with 3D Central-to-Peripheral ratio normalized to lung 
volume (nC/P3D) and with Outer to Inner ratio (O/I), as shown on the graph of Figure 3. 
The C/P ratio has been the common expression of the regional deposition, but the 
reciprocal of this ratio, the Outer-to-Inner ratio (O/I), was recommended by the recently 
published guidelines on the standardisation of techniques for the assessment of aerosol 
deposition from imaging8. Note that though the two methods of presenting the data are 
essentially equivalent, the resulting statistics in the form of correlation coefficients are 
different, if just slightly. We will use C/P ratio for the remainder of this paper to be 
consistent with our previous papers2,3. 
 
To compare the spatial distribution of aerosol with the planar 24h clearance data in 
absolute terms, we calculated the following ratio: clearance 24h1
clearance 24h
−  
where “24h clearance” represents the conducting airways deposition, and “1 – 24h 
clearance” the pulmonary deposition. This is an estimate of the central to peripheral 
deposition ratio based on clearance measurements. This has not been normalized for 
lung air volume in any way, so it is compared to the non-normalized c/p ratio obtained 
from SPECT (Figure 4). There is good correlation between the two parameters, but the 
fraction of deposition in the central conducting airways derived from clearance is much 
higher than the fraction predicted from spatial analysis of SPECT.  
The inherent difficulty of assigning spatial deposition data to anatomical regions has 
been addressed by Fleming and his colleagues3 by overlaying a morphological model in 
order to assign the deposition to the lung generations. Figure 5 shows the results 
assuming the standard International Commission on Radiological Protection (ICRP) 
definition of the conducting airways in the lung represented by generations 2–15 (CADF, 
conducting airways deposition fraction).  
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Figure 6 shows the results obtained by assuming the Weibel definition of the conducting 
airways. It can be seen that the TB deposition is under represented (p<0.0001) in Figure 
5 when using the ICRP definition suggesting that aerosol was being cleared from airways 
deeper than generation 15. This is indeed consistent with Weibel’s definition of 
conducting airways that includes a fraction of generations 16 to 19, thus improving the 
agreement as shown in Figure 6. The correlation coefficient (95% confidence interval) 
between Weibel definition of CADF and 24h clearance was 0.60 (0.36; 0.75) (Pearson 
Correlation Statistics). The coefficient of variation of estimating the 24h clearance from 
the Weibel definition of CADF was 20%. 
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Comparison of right vs. left lung aerosol deposition 
Planar imaging techniques used to measure aerosol deposition usually only consider the 
right lung because the left lung can overlap the stomach where radioactivity deposited in 
the mouth and swallowed cannot be separated. Thus, it is of interest to compare 
quantitatively the deposition in right and left lungs as deposition is known to be 
asymmetric12, using the 3D-SPECT images that permit the exclusion of counts in the 
stomach and more precise attenuation correction. This comparison is provided in terms 
of total deposition and regional deposition (3D Central-to-Peripheral ratio normalized to 
lung volume, and bronchial airways deposition fraction, BADF (generations 2–8)). Figure 
7 shows left vs. right lungs deposited activity. All the points are below the identity line, 
indicating that the total activity deposited is significantly lower in the left lung than in 
right lung (p<0.0001) at a mean ratio (Left/Right) of 0.87±0.1SD (n=22). However, 
when normalized to lung air volume using the following ratio:  
Lung Right of Volume Air / Lung Right in Activity
Lung Left of Volume Air / Lung Left in Activity
 
the left lung deposition is significantly higher (p=0.0085) with a mean ratio of 
1.08±0.12SD (n=22) (see Figure 8). 
A comparison of the 3D normalized Central-to-Peripheral ratio for the left and right lungs 
showed that it was significantly higher for left lung (p<0.0001) at a mean ratio 
(Left/Right) of 1.36±0.20SD (n=22) (see Figure 9).  These results were confirmed by the 
calculation of the bronchial airways deposition fraction (BADF), which was also 
significantly higher for left lung (p=0.0004) than for right lung (Figure 10). The mean 
ratio of BADF, defined by deposition in generations 2 to 8, (Left/Right) was 1.68±0.74SD 
(n=22). 
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A comparison of 24h clearance for the Right and Left Lungs is shown on Figure11; the 
difference was significant (p=0008), which gives an independent confirmation of the 
difference in regional distribution found from nC/P3D analysis.  
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Influence of the controlled parameters (particle size, depth of breathing, carrier gas) on 
aerosol deposition 
Influence of particle size and depth of breathing 
Figure 12 reproduces the graph in Figure 6 of the 24h clearance vs. conducting airways 
deposition fraction calculated with the Weibel Model, but with colors and shapes of the 
symbols to differentiate the individual inhalation experiments. There is a clear distinction 
that large particles (in red) are more centrally deposited than small particles (blue) , but 
no clear distinction between the deep (squares) and shallow (triangles) breathing 
patterns.  
These trends are confirmed by statistical analysis. nC/P3D, extra-thoracic (ET) deposition 
(from planar images), 24h clearance (from planar images), and total airway deposition 
in the trachea and right and left lungs (from planar images), were compared for the four 
following combinations: (i) large particles and shallow inhalation, (ii) large particles and 
deep inhalation, (iii) small particles and shallow inhalation, and (iv) small particles and 
deep inhalation. 3D normalized nC/P3D ratio, ET deposition, and 24h clearance were 
almost all higher for large particles whatever the breathing regime, whereas total airway 
deposition was higher for small particles. Two-factor Analysis Of Variance showed that 
the effect of particle size was statistically significant on nC/P3D ratio (p=0.0014), ET 
deposition (p=0.0037), 24h clearance (p<0.0001) and total airway deposition 
(p=0.0366),whereas the effect of inhalation parameters was not statistically significant 
on nC/P3Dratio (p=0.3949), ET deposition (p=0.9558), 24h clearance (p=0.7097), or  
total airway deposition (p=0.3481).  
Figure 13 shows total airway deposition, ET deposition, 24h clearance (conducting 
airways deposition) and 1-24h clearance (pulmonary deposition) for large and small 
particles, and deep and shallow inhalation; illustrating that the differences in deposition 
between large and small particles, were more significant than those occurring due to 
changes from deep to shallow inhalation regimes. 
Page 17 of 52
Mary Ann Liebert Inc., 140 Huguenot Street, New Rochelle, NY 10801
Journal of Aerosol Medicine and Pulmonary Drug Delivery
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only/Not for Distribution18 
 
 
Influence of the carrier gas: aerosol deposition breathing helium-oxygen vs. Air 
In Figure 12 the red clear symbols representing experiments with large particles and 
helium-oxygen are all below the solid red ones (representing experiments with large 
particles and air), meaning that breathing helium-oxygen has reduced deposition in the 
conducting airways determined from the planar 24h clearance measurement.  The effect 
of carrier gas can be further studied using the generational representation of deposition 
based on the 3D spatial images and the conceptual morphological model)1 as shown in 
Figure 14. The results are expressed as a percentage of deposited aerosol in the right 
and left lungs separately, from generations 2 (lobar bronchi) to 23 (alveoli) for 
participants H05A (Air) vs. H05B (helium), and H06A (Air) vs. H06B (helium). It is noted 
that right vs. left differences are less for helium-oxygen than for air, though the number 
of participants is insufficient to know if this is a consistent effect. However, this 
observation suggests that the heterogeneity of aerosol deposition with helium-oxygen as 
the carrier  
nC/P3D was 1.95 and 2.94 for the right and left lungs, respectively for H05A (Air), vs. 
1.38 and 1.69 for H05B (helium-oxygen). For H06A (Air), nC/P3D was 1.48 and 2.40 for 
right and left lungs respectively, vs. 1.23 and 1.47 for H06B (helium-oxygen). The 3D 
Central-to-Peripheral ratios normalized to lung volume were lower for the experiments 
with helium-oxygen than air, for the two participants and both for right and left lungs. 
These results suggest that deposition is less central and more peripheral when breathing 
helium-oxygen. 
 
Comparison of deposition when breathing air vs. helium-oxygen for all the participants 
inhaling large particles is given in Table 3, in the following regional terms: extra-thoracic 
(ET) deposition, 3D Central-to-Peripheral ratios normalized to lung volume (mean of 
Right+Left lungs), 24h clearance (mean of Right+Left lungs), total activity deposited in 
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the lungs and BADF.  For the “air + large particles” combination, the number of tests 
was 10 (n=10), and for “helium-oxygen + large particles” combination, the number was 
3 (n=3). These data support the premise that breathing helium-oxygen can increase 
peripheral deposition compared to central deposition.  
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Discussion 
The objective of this paper was to present the results of an analysis of the in vivo 
deposition data obtained in a clinical study, designed to provide data for model 
validation, but that also allows for the study of the influence of several inhalation 
parameters on aerosol deposition. The focus has been on comparisons of results from 
the 2D and 3D imaging approaches, thus maintaining continuity with the previous 
imaging literature; but also providing a bridge to future analysis that will focus on the 
inherent 3D character of the data and direct correlation with anatomy obtained from the 
CT images. 
The analysis described in this paper does not conform exactly to the new standard 
guidelines for using planar imaging13 and SPECT8 for measuring aerosol deposition. This 
was done to keep consistency with the companion paper describing the acquisition of the 
image database on  these healthy participants.  The deviations from the guidelines are in 
the planar analysis: (i) the use of a 10% contour to determine the lung region of interest 
(ROI) rather than the 15% recommended, (ii) the calculation of C/P (central to 
peripheral) ratios rather than O/I (Outer to inner) ratios.  It is felt that the difference in 
the planar ROI analysis technique is unlikely to make any significant difference to the 
results.  The effect of calculating O/I ratios instead of C/P has been investigated to some 
extent in this paper (Figure 3) and has been shown as expected to make only a very 
minor difference to the analysis.  
The analysis began with SPECT/CT accuracy. The comparison between total aerosol 
deposition in the lungs determined from planar (2D) and SPECT (3D) imaging showed 
that planar imaging gave slightly higher deposited activity compared to the SPECT, but 
that taking the clearance into account enabled  these differences to be reduced. 
The dose accountability for planar imaging showed good correlation between the total 
activity leaving the nebulizer assessed from (i) the difference in activity put into the 
nebulizer and that left after inhalation and (ii) the sum of the activity accounted for in 
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the body and exhalation filter. The difference between the mean activities was 2.7%, 
well within the 10% limit set by the ISAM guidelines13. 
The study enabled measures of regional distribution of aerosol deposition from the initial 
imaging measurement to be compared to the 24 h clearance measurements, which are 
thought to be a good measure of conducting airways deposition in healthy volunteers. 
The division of the lung into inner and outer spatial zones for analysis of the initial 
deposition pattern is known to only loosely approximate to conducting (central) and 
alveolated (peripheral airways).  This is particularly true for 2D imaging, but even in 3D 
there is a significant contribution of alveloated airways in the inner central region, and 
the conducting airways also penetrate out almost to the edge of the lung. The 
observation that the fraction in the inner central region is lower than the clearance 
observed on the 24 h measurements suggests that the influence of conducting airways 
in the outer peripheral region outweighs the impact of peripheral airways in the inner 
central region (Figure 4). This seems consistent with the suggestion by Weibel10 that the 
conducting airways are found as deep into the airway tree as generation 19. 
 
The importance of deposition in the smaller conducting airways is confirmed in the 
analysis of deposition by generation. The results obtained assuming the standard 
International Commission on Radiological Protection (ICRP) definition of the conducting 
airways in the lung represented by generations 2–1514 and those obtained by assuming 
the Weibel definition of the conducting airways, suggested that aerosol was being 
cleared from airways deeper than generation 1510. The majority of these airways are 
located in shells 9 and 10 close to the other edge of the lung. 
The acquisition of 3D data from SPECT enabled detailed study on deposition in the left 
lung without significant impact of activity in the stomach15.  Comparison of right vs. left 
lung aerosol deposition showed that the total activity deposited was significantly lower in 
the left lung than in right lung.  This was expected due to the lower air volume in the left 
lung.  However the L/R ratio of deposition was in fact a little higher than the ratio of air 
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volumes, which was 0.835.When normalized to lung air volume the left lung deposition 
was significantly higher than the right, demonstrating that left lung deposition was 
greater than would be expected relative to the right on the basis of lung air volume 
alone.  
It was also noted that central deposition was significantly higher for left lung both from 
analysis of the initial deposition pattern and the 24 h clearance. The difference between 
right and left lungs in terms of 24h clearance was considerably smaller than the 
difference for nC/P3D or BADF (generations 2 to 8). BADF, and to a lesser extent 
nC/P3D, depend on deposition in the bronchial airways up to generation 8. This suggests 
that most of the difference in the left and right lung deposition occurs in the first few 
generations rather than the smaller conducting airways. The 24h measurement will be 
dominated by the deposition in the smaller conducting airways which have a much larger 
relative volume. The finding that the left lung has greater central deposition than the 
right is consistent with previous results. Studies aiming to target aerosol delivery using 
bolus techniques have shown that shallow boluses targeted toward the central 
conducting airways are preferentially deposited in the left lung, whereas those targeted 
toward the lung periphery are more evenly distributed between left and right lungs12. 
The study on the influence of particle size and depth of breathing showed, as expected, a 
significant effect on deposition pattern due to particle size. The smaller particles had a 
slightly increased whole lung deposition, 87% compared to 77%. These values were 
considerably higher than those predicted from conventional empirical models of aerosol 
deposition in the lung.  These generally predict that for particles of this size, more of the 
aerosol will be exhaled14,15. This may be related to hygroscopic growth within the lung 
causing particles that would have been exhaled to be deposited in the lung due to their 
increased size.  Future work will involve the application of computer models of deposition 
to this data in order to provide an explanation for this observation. 
The larger particles had greater deposition in the ET region and in the central pulmonary 
airways. This was demonstrated in both the initial deposition pattern (nC/P3D) and in 
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the 24 h clearance results and is consistent with expected results from modeling14 and 
from previous experimental studies16. The influence of inhalation parameters was less 
clear. Deep inhalation resulted in higher total deposition in the lung with less in the ET 
region and central pulmonary airways. However this effect was smaller and more 
variable and not statistically significant. The influence of using helium-oxygen as the 
carrier gas compared to air has been studied for the larger particles. Breathing helium-
oxygen increased total lung deposition and reduced deposition in the ET region and the 
conducting airways fraction of pulmonary deposition17,18. However, the number of studies 
performed was considered too small to perform statistical analysis. Investigation of the 
estimated deposition per generation suggested that helium-oxygen may also decrease 
the heterogeneity of aerosol deposition between left and right lungs. These results 
suggest that altering the carrier gas may help in targeting aerosol to specific parts of the 
airway tree. The reason for this effect is currently being studied using computer 
modeling of deposition. There may be effects due to the different density and viscosity of 
helium-oxygen. 
The 24 h clearance measurement was particularly good at distinguishing the effect of 
particle size, providing complete separation between the two groups of measurements 
using the large and small particle sizes.  By contrast, the conducting airways deposition 
fraction using the Weibel definition of airways (wdf) was less good at separating the 
groups. Although there was significant correlation between wdf and 24 h clearance, there 
was considerable overlap in wdf values between the groups.  This points to a limitation in 
precision in the shell to generation conversion.  This can be explained by the significant 
proportion of conducting airway deposition found in the small airways of generations 15-
19 mentioned above. The conceptual model used to analyze the images treats the acinus 
as a unit consisting of airways from generation 15-23.  It therefore cannot easily 
separate deposition on these peripheral conducting airways and the alveoli, giving a limit 
on its ability to assess total conducting airways deposition.     
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In conclusion this study has demonstrated the value of three dimensional radionuclide 
imaging in assessing the regional distribution of aerosol deposition within the lung. The 
expected influence of particle size has been demonstrated and new data on the regional 
distribution pattern has been presented using comparison of initial deposition with 24 h 
clearance measurements. New information on the difference in deposition in left and 
right lungs has also been provided. 
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Tables 
 
Aerosol size 
Large 
MMAD = 5.8 µm 
GSD = 1.6 
Small 
MMAD = 3.1 µm 
GSD = 1.5 
Table 1 Aerosol description. MMAD (Mass Median Aerodynamic Diameter), GSD 
(Geometric Standard Deviation) 
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Breathing pattern 
Deep  
 
TV = 1000 ml 
f = 9 bpm 
Ti = 3.33 s 
VE = 9 L/min 
IFR = 18 L/min 
Shallow  
 
TV = 600 ml 
f = 15 bpm 
Ti = 2 s 
VE = 9 L/min 
IFR = 18 L/min 
Table 2 Breathing pattern description. TV (Tidal volume), f (Breathing 
frequency in breaths per minute), Ti (Inspiration time), VE (Minute ventilation 
defined by fTVVE ×= ), IFR (Inspiratory flow rate defined by Ti
TV
IFR =
) 
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 air + large particles 
(n=10) 
(mean±95% confidence 
interval) 
helium-oxygen + large 
particles (n=3) 
(mean±95% confidence 
interval) 
ET deposition (percentage of 
inhaled) 
19.2±4.7% 10.4±5.0% 
nC/P 3D (mean of Right+Left 
lungs) 
2.42±0.45 1.56±0.26 
24h clearance (mean of 
Right+Left lungs) 
0.51±0.04 0.41±0.04 
total airway deposition 
(percentage of inhaled) 
76.7±4.8% 84.8±2.3% 
BADF deposition 
(generations 2–8) 
0.122±0.040 0.055±0.032 
Table 3 Extra-thoracic deposition, central-to-peripheral ratio, 24h clearance, 
total airway deposition and BADF for “air+large particles” vs. “helium-
oxygen+large particles” 
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List of Figures 
 
- Figure 1 Total deposition in each lung determined from planar (2D) and SPECT (3D) 
imaging, corrected for mucociliary clearance. The line is the identity line. 
- Figure 2 The total activity leaving the nebulizer assessed from (i) the difference in 
activity put into the nebulizer and that left after inhalation and (ii) the sum of the 
activity accounted for in the body and exhalation filter by planar imaging, corrected 
for mucociliary clearance. The line is the identity line. 
- Figure 3 The variation of 24h clearance with 3D normalized central-to-peripheral 
ratio and Outer to Inner ratio. The lines are the least squares linear regressions.  
- Figure 4 The variation of “24h clearance / (1 – 24h clearance)” with 3D central-to-
peripheral ratio. The dashed line is the identity line; the solid line is the least squares 
linear regression. 
- Figure 5 The variation of 24h clearance with the estimated fractional deposition in 
generations 2–15 (CADF). The line is the identity line. 
- Figure 6 The variation of 24h clearance with conducting airways deposition fraction 
assuming the definition of the conducting airways in the Weibel Model. The line is the 
identity line. 
- Figure 7 Comparison of deposition in the right and left lungs from 3D-SPECT. The 
line is the identity line. 
- Figure 8 Deposition of activity in right and left lungs from 3D-SPECT normalized to 
lung volume.  The line is the identity line. 
- Figure 9 Spatial deposition: 3D normalized Central-to-Peripheral ratio in right and 
left lungs. The line is the identity line. 
- Figure 10 Airway deposition: bronchial airways deposition fraction (BADF, 
generations 2–8) in right and left lungs.  The line is the identity line. 
- Figure 11 24h clearance in right and left lungs.  The line is the identity line. 
- Figure 12 The variation of 24h clearance with conducting airways deposition fraction 
assuming the definition of the conducting airways in the Weibel Model. The 
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parameters have been differentiated with symbols and color codes.  The line is the 
identity line. 
- Figure 13 Total airway deposition, ET deposition, and 24h clearance (conducting 
airways deposition) for large and small particles, and deep and shallow regimes. 
Histograms are the Means, error bars the Standard Deviation. 
- Figure 14 Generational deposition for healthy participants whose varying parameter 
was carrier gas. 
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Figure 1 Total deposition in each lung determined from planar (2D) and SPECT (3D) imaging, corrected for 
mucociliary clearance. The line is the identity line.  
256x158mm (96 x 96 DPI)  
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Figure 2 The total activity leaving the nebulizer assessed from (i) the difference in activity put into the 
nebulizer and that left after inhalation and (ii) the sum of the activity accounted for in the body and 
exhalation filter by planar imaging, corrected for mucociliary clearance. The line is the identity line.  
256x158mm (96 x 96 DPI)  
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Figure 3 The variation of 24h clearance with 3D normalized central-to-peripheral ratio and Outer to Inner 
ratio. The lines are the least squares linear regressions.  
256x158mm (96 x 96 DPI)  
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Figure 4 The variation of “24h clearance / (1 – 24h clearance)” with 3D central-to-peripheral ratio. The 
dashed line is the identity line; the solid line is the least squares linear regression.  
256x158mm (96 x 96 DPI)  
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Figure 5 The variation of 24h clearance with the estimated fractional deposition in generations 2–15 (CADF). 
The line is the identity line.  
256x158mm (96 x 96 DPI)  
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Figure 6 The variation of 24h clearance with conducting airways deposition fraction assuming the definition 
of the conducting airways in the Weibel Model. The line is the identity line.  
256x158mm (96 x 96 DPI)  
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Figure 7 Comparison of deposition in the right and left lungs from 3D-SPECT. The line is the identity line.  
256x159mm (96 x 96 DPI)  
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Figure 8 Deposition of activity in right and left lungs from 3D-SPECT normalized to lung volume.  The line is 
the identity line.  
256x159mm (96 x 96 DPI)  
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Figure 9 Spatial deposition: 3D normalized Central-to-Peripheral ratio in right and left lungs. The line is the 
identity line.  
256x159mm (96 x 96 DPI)  
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Figure 10 Airway deposition: bronchial airways deposition fraction (BADF, generations 2–8) in right and left 
lungs.  The line is the identity line.  
256x159mm (96 x 96 DPI)  
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Figure 11 24h clearance in right and left lungs.  The line is the identity line.  
256x159mm (96 x 96 DPI)  
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Figure 12 The variation of 24h clearance with conducting airways deposition fraction assuming the definition 
of the conducting airways in the Weibel Model. The parameters have been differentiated with symbols and 
color codes.  The line is the identity line.  
256x159mm (96 x 96 DPI)  
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Figure 13 Total airway deposition, ET deposition, and 24h clearance (conducting airways deposition) for 
large and small particles, and deep and shallow regimes. Histograms are the Means, error bars the Standard 
Deviation.  
173x135mm (96 x 96 DPI)  
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Figure 13 Total airway deposition, ET deposition, and 24h clearance (conducting airways deposition) for 
large and small particles, and deep and shallow regimes. Histograms are the Means, error bars the Standard 
Deviation.  
173x135mm (96 x 96 DPI)  
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Figure 13 Total airway deposition, ET deposition, and 24h clearance (conducting airways deposition) for 
large and small particles, and deep and shallow regimes. Histograms are the Means, error bars the Standard 
Deviation.  
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Figure 14 Generational deposition for healthy participants whose varying parameter was carrier gas.  
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Figure 14 Generational deposition for healthy participants whose varying parameter was carrier gas.  
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Figure 14 Generational deposition for healthy participants whose varying parameter was carrier gas.  
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Figure 14 Generational deposition for healthy participants whose varying parameter was carrier gas.  
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